Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the ...
Lipoprotein(a) is a genetic cardiovascular risk factor affecting 20% of the global population, with no routine testing despite guideline recommendations. Current therapies offer modest Lp(a) reduction ...
President Donald Trump’s deals with pharmaceutical companies are likely to have only a limited impact on Americans’ drug spending, experts say. Since Sept. 30, the Trump administration has struck ...
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of RxSmartSaver powered by GoodRx at Giant Eagle ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果